title: PC-SPES: current evidence and remaining questions.
authors.affiliation: Health Content, American Cancer Society, Atlanta, GA, USA.
authors.forename: T
authors.initials: T
authors.lastname: Ades
authors.forename: T
authors.initials: T
authors.lastname: Gansler
authors.forename: M
authors.initials: M
authors.lastname: Miller
authors.forename: D S
authors.initials: DS
authors.lastname: Rosenthal
mesh_terms: D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004365:Drugs, Chinese Herbal; D006801:Humans; D008297:Male; D010936:Plant Extracts / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D011471:Prostatic Neoplasms / Q000188:drug therapy*
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D004365:Drugs, Chinese Herbal; D010936:Plant Extracts; C114209:herbal preparation PC-SPES